Global Lung Cancer Therapy Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The research report on the global Lung Cancer Therapy Market provides the micro- and macroscopic analysis of the market that is likely to have a huge influence on the business expansion over the years. The report offers a complete, detailed outline of the Lung Cancer Therapy market in order to gain better insights of the market drivers and strategies to survive on the global platform. The report covers a wide-scope market analysis for better explanation of the business performance and both qualitative and quantitative aspects of the Lung Cancer Therapy industry. In addition, the regional segmentation by Product type Radiation Therapy, Chemotherapy, Targeted Therapies, Immunotherapy, , by Application Hospitals, Clinics, Other, , provides the demographic status, supply & demand chain, and consumer preference details. The provision of pricing details, technological developments, and economic growth of the Lung Cancer Therapy market in this research report helps better comprehend the market development. Additionally, the various research methodologies provide well-defined market scope for gaining more knowledge about industry analysis and forecast estimation of the Lung Cancer Therapy market.

Data provided by Extent Research. Source: https://www.extentresearch.com/lung-cancer-therapy-market

The pictorial and informative representation of the market drivers and opportunities for Lung Cancer Therapy market has been well explained through the different segmentation including product, application, competitive landscape, and geography. In addition to this, the comprehensive detailing of industrial strategies and government policies provides a clear view of the market dynamics. The explanation regarding competitive players GlaxoSmithKline, Menarini, Pfizer, Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Company, Abbott, Akebia Therapeutics, Agennix AG, offer information including recent developments, market growth strategies, new product launches, and several customized solutions that will profit the global Lung Cancer Therapy market. The research report provides a complete overview and research of the Lung Cancer Therapy market.

Competitive Analysis:

The competitive landscape detailing provides more knowledge associated with historical and future market plans, strategies, business operations, and acquisitions. These parameters provide realistic Lung Cancer Therapy industry data.

Lung Cancer Therapy report insights:

Market Strategies, threats, technological advancements, government policies, opportunities, and challenges
Forecast market trends, market size, and revenue
Details regarding market volume, pricing policies, import-export share, value chain, and latest marketing trends
Use of strategy analysis coupled with tools & primary & secondary resources for market study

Global Lung Cancer Therapy market research report provides:

Overview and analysis of market drivers, opportunities, restraints, threats, and challenges
Overview and analysis of market segmentation
Business strategies and expansion
Market growth, share, distribution, and status on the regional and global platform

Report Scope and Market Segmentation

ATTRIBUTES	Global Lung Cancer Therapy Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Lung Cancer Therapy Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lung Cancer Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Radiation Therapy
        1.2.3 Chemotherapy
        1.2.4 Targeted Therapies
        1.2.5 Immunotherapy
    1.3 Market by Application
        1.3.1 Global Lung Cancer Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Lung Cancer Therapy Market Perspective (2017-2035)
    2.2 Lung Cancer Therapy Growth Trends by Region
        2.2.1 Lung Cancer Therapy Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Lung Cancer Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Lung Cancer Therapy Forecasted Market Size by Region (2023-2035)
    2.3 Lung Cancer Therapy Market Dynamics
        2.3.1 Lung Cancer Therapy Industry Trends
        2.3.2 Lung Cancer Therapy Market Drivers
        2.3.3 Lung Cancer Therapy Market Challenges
        2.3.4 Lung Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Lung Cancer Therapy Players by Revenue
        3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2017-2022)
        3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Lung Cancer Therapy Revenue
    3.4 Global Lung Cancer Therapy Market Concentration Ratio
        3.4.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2021
    3.5 Lung Cancer Therapy Key Players Head office and Area Served
    3.6 Key Players Lung Cancer Therapy Product Solution and Service
    3.7 Date of Enter into Lung Cancer Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Therapy Breakdown Data by Type
    4.1 Global Lung Cancer Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2023-2035)
5 Lung Cancer Therapy Breakdown Data by Application
    5.1 Global Lung Cancer Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Lung Cancer Therapy Market Size (2017-2035)
    6.2 North America Lung Cancer Therapy Market Size by Type
        6.2.1 North America Lung Cancer Therapy Market Size by Type (2017-2022)
        6.2.2 North America Lung Cancer Therapy Market Size by Type (2023-2035)
        6.2.3 North America Lung Cancer Therapy Market Share by Type (2017-2035)
    6.3 North America Lung Cancer Therapy Market Size by Application
        6.3.1 North America Lung Cancer Therapy Market Size by Application (2017-2022)
        6.3.2 North America Lung Cancer Therapy Market Size by Application (2023-2035)
        6.3.3 North America Lung Cancer Therapy Market Share by Application (2017-2035)
    6.4 North America Lung Cancer Therapy Market Size by Country
        6.4.1 North America Lung Cancer Therapy Market Size by Country (2017-2022)
        6.4.2 North America Lung Cancer Therapy Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Lung Cancer Therapy Market Size (2017-2035)
    7.2 Europe Lung Cancer Therapy Market Size by Type
        7.2.1 Europe Lung Cancer Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Lung Cancer Therapy Market Size by Type (2023-2035)
        7.2.3 Europe Lung Cancer Therapy Market Share by Type (2017-2035)
    7.3 Europe Lung Cancer Therapy Market Size by Application
        7.3.1 Europe Lung Cancer Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Lung Cancer Therapy Market Size by Application (2023-2035)
        7.3.3 Europe Lung Cancer Therapy Market Share by Application (2017-2035)
    7.4 Europe Lung Cancer Therapy Market Size by Country
        7.4.1 Europe Lung Cancer Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Lung Cancer Therapy Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Lung Cancer Therapy Market Size (2017-2035)
    8.2 Asia-Pacific Lung Cancer Therapy Market Size by Type
        8.2.1 Asia-Pacific Lung Cancer Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Lung Cancer Therapy Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Lung Cancer Therapy Market Share by Type (2017-2035)
    8.3 Asia-Pacific Lung Cancer Therapy Market Size by Application
        8.3.1 Asia-Pacific Lung Cancer Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Lung Cancer Therapy Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Lung Cancer Therapy Market Share by Application (2017-2035)
    8.4 Asia-Pacific Lung Cancer Therapy Market Size by Region
        8.4.1 Asia-Pacific Lung Cancer Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Lung Cancer Therapy Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Lung Cancer Therapy Market Size (2017-2035)
    9.2 Latin America Lung Cancer Therapy Market Size by Type
        9.2.1 Latin America Lung Cancer Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Lung Cancer Therapy Market Size by Type (2023-2035)
        9.2.3 Latin America Lung Cancer Therapy Market Share by Type (2017-2035)
    9.3 Latin America Lung Cancer Therapy Market Size by Application
        9.3.1 Latin America Lung Cancer Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Lung Cancer Therapy Market Size by Application (2023-2035)
        9.3.3 Latin America Lung Cancer Therapy Market Share by Application (2017-2035)
    9.4 Latin America Lung Cancer Therapy Market Size by Country
        9.4.1 Latin America Lung Cancer Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Lung Cancer Therapy Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Lung Cancer Therapy Market Size (2017-2035)
    10.2 Middle East & Africa Lung Cancer Therapy Market Size by Type
        10.2.1 Middle East & Africa Lung Cancer Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Lung Cancer Therapy Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Lung Cancer Therapy Market Share by Type (2017-2035)
    10.3 Middle East & Africa Lung Cancer Therapy Market Size by Application
        10.3.1 Middle East & Africa Lung Cancer Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Lung Cancer Therapy Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Lung Cancer Therapy Market Share by Application (2017-2035)
    10.4 Middle East & Africa Lung Cancer Therapy Market Size by Country
        10.4.1 Middle East & Africa Lung Cancer Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Lung Cancer Therapy Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction
        11.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2017-2022)
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 Menarini
        11.2.1 Menarini Company Details
        11.2.2 Menarini Business Overview
        11.2.3 Menarini Lung Cancer Therapy Introduction
        11.2.4 Menarini Revenue in Lung Cancer Therapy Business (2017-2022)
        11.2.5 Menarini Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Lung Cancer Therapy Introduction
        11.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2017-2022)
        11.3.5 Pfizer Recent Developments
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Lung Cancer Therapy Introduction
        11.4.4 Roche Revenue in Lung Cancer Therapy Business (2017-2022)
        11.4.5 Roche Recent Developments
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Lung Cancer Therapy Introduction
        11.5.4 Merck Revenue in Lung Cancer Therapy Business (2017-2022)
        11.5.5 Merck Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Lung Cancer Therapy Introduction
        11.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 Sanofi-Aventis
        11.7.1 Sanofi-Aventis Company Details
        11.7.2 Sanofi-Aventis Business Overview
        11.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction
        11.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2017-2022)
        11.7.5 Sanofi-Aventis Recent Developments
    11.8 Eli Lilly and Company
        11.8.1 Eli Lilly and Company Company Details
        11.8.2 Eli Lilly and Company Business Overview
        11.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction
        11.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2017-2022)
        11.8.5 Eli Lilly and Company Recent Developments
    11.9 Abbott
        11.9.1 Abbott Company Details
        11.9.2 Abbott Business Overview
        11.9.3 Abbott Lung Cancer Therapy Introduction
        11.9.4 Abbott Revenue in Lung Cancer Therapy Business (2017-2022)
        11.9.5 Abbott Recent Developments
    11.10 Akebia Therapeutics
        11.10.1 Akebia Therapeutics Company Details
        11.10.2 Akebia Therapeutics Business Overview
        11.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction
        11.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2017-2022)
        11.10.5 Akebia Therapeutics Recent Developments
    11.11 Agennix AG
        11.11.1 Agennix AG Company Details
        11.11.2 Agennix AG Business Overview
        11.11.3 Agennix AG Lung Cancer Therapy Introduction
        11.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2017-2022)
        11.11.5 Agennix AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Lung Cancer Therapy Market